Want to join the conversation?
$MDT Product Update: MDT announced U.S. FDA approval & commercial launch of Advisa SR MRI SureScan single-chamber pacemaker with 5076 MRI lead, which allows for MRI scans positioned on any region of body without restrictions. New system includes Advisa SR MRI pacemaker & a SureScan lead, which must be used together to be considered MR-conditional.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.